Study On Patient Support Program Impact Piques EMA's Interest
The pharmaceutical industry's renewed effort to find a pragmatic solution to managing adverse events from patient support programs has drawn the European Medicines Agency's attention.
You may also be interested in...
The European Medicines Agency is inviting feedback from organizations interested in delivering a training program to the members of the European medicines regulatory network to improve their big data analysis and assessment skills.
The UK has started monitoring whether clinical trial sponsors are fulfilling responsibilities to make their research open and transparent.
A number of new medicines are moving closer to the EU market after the European Medicines Agency recommended in favor of their approval.